Logo
Banner

Vacuolin-1

Cat No.:
LIA001
Price:
Chemical Structure:

Description of Vacuolin-1

Vacuolin-1 is a potent inhibitor of cell-penetrating lysosomal exocytosis. Vacuolin-1 blocks lysosomal Ca2+-dependent exocytosis, preventing the release of lysosomal contents without affecting the reclosure process. Vacuolin-1 is a potent and selective PIKfyve inhibitor that inhibits late autophagy by impairing lysosomal maturation.

Product Information of Vacuolin-1

Purity
0.9882
Molecular Weight
577.42
Formula
C26H24IN7O
CAS Number
351986-85-1
Pack Size
5 mg/10 mg/ 50 mg/100 mg
Storage
Store at -20°C, stored under nitrogen.
Shelf-Life
6 months(stored in solvent).
1 month (stored under nitrogen).
Shipping Conditions
Room temperature in continental US, may vary elsewhere.
In Vitro Studies
Vacuolin-1 (1 μM; Pretreatment 1 hour) blocks ionomycin-induced exocytosis of lysosomes but not of enlargeosomes. It results in vacuolation of lysosomes (A) and complete inhibition of the surface expression of Lamp-1.
Vacuolin-1 (1 μM; 20-180 min) disrupts the segregation of inner and limiting membranes characteristic of endosomes and lysosomes. Ultrastructural analysis also shows that vacuolin-1 favours fusion of inner and limiting membranes.
Vacuolin-1 (5 or 10 μM; 2 hours) blocks the Ca2+-dependent release of β-hexosaminidase from lysosomes. In HeLa cells, ionomycin results in the expected release of 18-20% of lysosomal β-hexosaminidase. But when cells pretreated with vacuolin-1, releases no more β-hexosaminidase compared with cells that are not exposed to ionomycin (4%).

For research use only, not intended for any clinical use.